Key result
Endovascular treatment plus PAH-specific therapy successfully resolves left main coronary compression in HIV-associated PAH.
Why the study?
In the era of antiretroviral therapy, increased life expectancy in HIV patients has shifted clinical focus toward complications, including rare and severe cardiovascular conditions such as left main coronary artery compression syndrome due to HIV-associated PAH.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case report highlights that left main coronary artery compression from a dilated pulmonary artery in HIV-associated PAH can be successfully managed with endovascular intervention and PAH-specific medical therapy.
Human immunodeficiency virus (HIV) is characterized by slow and gradual damage to the immune system. In recent years, its incidence has increased by an average of 10% per year. However, in the era of antiretroviral therapy, the life expectancy of this cohort of patients has increased, shifting the focus to complications, including cardiovascular ones. This article describes a patient with pulmonary arterial hypertension (PAH) associated with HIV infection who developed a rare, severe complication — left main coronary artery compression syndrome due to a dilated pulmonary artery. It describes successful endovascular treatment and the selection of PAH-specific therapy.
No takes yet. Share an insight, caveat, or question.
Chitanava et al. (2026) conducted a case report in Left main coronary artery compression syndrome due to pulmonary arterial hypertension associated with HIV infection (n=1). Endovascular treatment and PAH-specific therapy was evaluated on Successful treatment of left main coronary artery compression syndrome. Endovascular treatment combined with PAH-specific therapy successfully managed a patient(n=1) with left main coronary artery compression caused by HIV-associated pulmonary arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: